Study of Effect of Guided Meditation on Spiritual wellbeing and Quality of Life In Patients of End Stage Renal Disease (ESRD) on Maintenance Haemodialysis
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Improvement in score of Kidney Disease Related Quality of Life (KDQOL) assessment tool.
研究概览
简要总结
Chronic Kidney Disease (CKD) is a common non communicable disease requiring lifelong treatment. It can lead to significant morbidity, social isolation, emotional distress, family strain, and lifestyle disruptions due to therapeutic measures, dietary restrictions and dialysis needs. These challenges significantly impact patients’ and their families’ quality of life. The Kidney Disease Quality of Life (KDQOL) questionnaire is an important tool for assessing the
quality of life in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). It evaluates the impact of the disease and its treatment on patients’ physical, mental,
and social well-being, helping healthcare providers tailor interventions to improve overall quality of life.
Spiritual well-being is a key determinant of quality of life, influencing how individuals cope with illness and life challenges. It can provide a sense of purpose, comfort, and support,
which are crucial for overall mental and emotional health. This aspect of well-being is especially important for managing chronic conditions like CKD and ESRD.
Meditation is recognized as an important method to enhance spiritual well-being, reduce the psychological burden of chronic diseases, and improve overall well-being. It helps
individuals manage stress, gain clarity, and find inner peace, contributing to better mental and emotional health. Dejection and hopelessness are commonly encountered in patients in end
stage kidney disease. This study is required to see the tangible difference meditation and spiritual practices can make in improvement of KDQOL, sleep, anxiety, stress and overall attitude of
patients in dealing with end stage chronic disease like ESRD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients of End Stage Renal Disease on Maintenance Hemodialysis.
排除标准
- •Age Less than 18 years.
- •Age more than 70 years Active malignancy in last 2 years.
结局指标
主要结局
Improvement in score of Kidney Disease Related Quality of Life (KDQOL) assessment tool.
时间窗: Baseline and Six Weeks
次要结局
未报告次要终点
研究者
Bhalendu Suryakant Vaishnav
Pramukhswami Medical College
